SCHEMBL7019407

SCHEMBL7019407

COc1[c]cc(-c2cc3nnccc3[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 7/20 0.38
CDK1 P06493 7/20 0.38
CCNB1 P14635 7/20 0.38
CCNB3 Q8WWL7 7/20 0.38
GSK3A P49840 6/20 0.38
GSK3B P49841 6/20 0.38
CDK5 Q00535 3/20 0.38
CDK5R1 Q15078 3/20 0.38
FYN P06241 1/20 0.33
RIPK1 Q13546 1/20 0.32
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019826 0.82 RIPK1 (0.42) CCNB2CDK1CCNB1CCNB3GSK3A
SCHEMBL7103387 0.77 KDM4E (0.39) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL7016752 0.75 EGFR (0.35) CCNB2CDK1CCNB1CCNB3GSK3A
SCHEMBL6286415 0.74 TUBB4A (0.38) CCNB2CDK1CCNB1CCNB3GSK3A
SCHEMBL6494995 0.70 KDM4E (0.38) CCNB2CDK1CCNB1CCNB3FYN
SCHEMBL6286410 0.69 PARP1 (0.42) KDM4EMAPT
SCHEMBL7016833 0.68 CCNB2 (0.42) CCNB2CDK1CCNB1CCNB3GSK3A
SCHEMBL7019380 0.68 RIPK1 (0.41) CCNB2CDK1CCNB1CCNB3GSK3A
SCHEMBL7104266 0.65 PDGFRB (0.38) KDM4EMAPT
SCHEMBL14438040 0.63 NR3C1 (0.37) CCNB2CDK1CCNB1CCNB3GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294718-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY LLC (US) 2003-03-26 EP disclosed
WO-2001096336-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY (US) 2001-12-20 WO disclosed